On the last day of trading, <a class="manualbacklink" target="_blank" href="https://mintgenie.livemint.com/stocks/glenmark-pharmaceuticals-S0003191">Glenmark Pharmaceuticals</a> had a total volume of 190,232 shares on the Bombay Stock Exchange (BSE). The closing price for the stock was ₹814.

Glenmark Pharmaceuticals share price Live :Glenmark Pharmaceuticals closed at ₹814 on last trading day

Glenmark Pharmaceuticals Share Price Live blog for 14 Sep 2023

The last day of trading for Glenmark Pharmaceuticals saw the stock open at ₹814 and close at the same price. The stock reached a high of ₹864.75 and a low of ₹814. The market capitalization of the company is ₹24,358.17 crore. The 52-week high for the stock is ₹836.3 and the 52-week low is ₹363.8. The BSE volume for the stock was 190,232 shares.Disclaimer: This is an AI-generated live blog and has not been edited by MintGenie staff.

Glenmark Pharmaceuticals stock price went up today, 14 Sep 2023, by 6.05 %. The stock closed at 814 per share. The stock is currently trading at 863.25 per share. Investors should monitor Glenmark Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.

Coromandel International Share Price Live blog for 14 Sep 2023

Linde India Share Price Live blog for 14 Sep 2023

Computer Age Management Services Share Price Live blog for 14 Sep 2023

CESC Share Price Live blog for 14 Sep 2023

HEG Share Price Live blog for 14 Sep 2023

Rashtriya Chemicals & Fertilizers Share Price Live blog for 14 Sep 2023

Canfin Homes Share Price Live blog for 14 Sep 2023

Castrol India Share Price Live blog for 14 Sep 2023

Mahindra Holidays & Resorts Share Price Live blog for 14 Sep 2023

Tata AIG General Insurance launches Tata AIG Elder Care health policy; all you need to know

Tata AIG General Insurance introduces health insurance policy for senior citizens, offering extensive medical coverage and home care services.

FPIs turn net sellers in September after 6 straight months of inflows; will this trend continue?

Foreign portfolio investors (FPIs) turned sellers in September, selling Indian equities worth ₹14,768 crore due to rising US bond yields and higher crude oil prices. However, Indian benchmarks delivered positive returns, driven by strong domestic investor inflows and the successful G20 summit.

Markets in September: Sensex, Nifty turn positive, only 1 index in the red; What lies ahead?

Indian indices rebounded in September after weak August. Sensex was up 1.5%, while Nifty 2%. PSU banks, energy, auto, realty, and metal sectors were top gainers.

Phillip Capital upgrades Vedanta to 'buy' on positive demerger outlook; expects 30% upside

Vedanta announced plan to demerge business units into separate companies, aims to unlock value and attract investments. The entire process is expected to be completed by September FY25.

A first in 10 years: Currency in circulation drops in H1

It declined mainly because of the withdrawal of ₹2000 bank notes, announced on May 19. According to the latest RBI data, ₹2000 notes worth ₹3.46 trillion have been returned, and that is 96 per cent of the ₹3.56 trillion of the ₹2000 notes in circulation till May 19.